| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAB6A | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | TSSK2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | PIK3CB | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | TEAD3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | DNAAF2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | NBPF9 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | SH3PXD2A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | APLF | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | LDLRAD2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | JAG1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
